Climb Bio (CLYM) Institutional Ownership $1.63 +0.02 (+1.24%) As of 08/13/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Climb Bio (NASDAQ:CLYM)CurrentInstitutional OwnershipPercentage69.76%Number ofInstitutional Buyers(last 12 months)16TotalInstitutional Inflows(last 12 months)$43.01MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$568.41K Get CLYM Insider Trade Alerts Want to know when executives and insiders are buying or selling Climb Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CLYM Institutional Buying and Selling by Quarter Climb Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2025Stonepine Capital Management LLC116,147$144K0.1%N/A0.172% 8/12/2025 JPMorgan Chase & Co.210,122$261K0.0%-31.4%0.311% 8/8/2025 Geode Capital Management LLC311,721$387K0.0%-53.7%0.461% 8/8/2025 Nan Fung Trinity HK Ltd.463,654$575K0.1%N/A0.686% 8/1/2025 Y Intercept Hong Kong Ltd127,952$159K0.0%N/A0.189% 6/27/2025Goldman Sachs Group Inc.120,742$147K0.0%N/A0.179% 5/16/2025Goldman Sachs Group Inc.120,742$147K0.0%N/A0.179% 5/16/2025AQR Capital Management LLC21,808$27K0.0%N/A0.032% 5/16/2025Allostery Investments LP244,988$299K0.4%N/A0.363% 5/16/2025ADAR1 Capital Management LLC119,320$146K0.0%N/A0.177% 5/15/2025RA Capital Management L.P.31,419,267$38.33M0.6%N/A46.495% 5/14/2025Affinity Asset Advisors LLC1,500,000$1.83M0.2%N/A2.220% 5/13/2025 Persistent Asset Partners Ltd145,760$178K0.1%N/A0.216% 5/12/2025 Nuveen LLC39,034$48K0.0%N/A0.058% 5/9/2025 Charles Schwab Investment Management Inc.70,093$86K0.0%N/A0.104% 5/8/2025XTX Topco Ltd27,660$34K0.0%N/A0.041% 5/7/2025 TD Asset Management Inc89,400$109K0.0%N/A0.132% 4/30/2025 Peapod Lane Capital LLC553,816$676K0.8%N/A0.821% 4/29/2025 Bank of New York Mellon Corp64,914$79K0.0%N/A0.096% (Data available from 1/1/2016 forward) CLYM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CLYM shares? During the previous two years, 19 institutional investors and hedge funds held shares of Climb Bio. The most heavily invested institutionals were RA Capital Management L.P. ($38.33M), Affinity Asset Advisors LLC ($1.83M), Peapod Lane Capital LLC ($676K), Nan Fung Trinity HK Ltd. ($575K), Geode Capital Management LLC ($387K), Allostery Investments LP ($299K), and JPMorgan Chase & Co. ($261K).Learn more on Climb Bio's institutional investors. What percentage of Climb Bio's stock is owned by institutional investors? 69.76% of Climb Bio's stock is owned by institutional investors. Learn more on CLYM's institutional investor holdings. Which institutional investors have been buying Climb Bio's stock? Of the 17 institutional investors that purchased Climb Bio's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($31.42M), Affinity Asset Advisors LLC ($1.50M), Peapod Lane Capital LLC ($553.82K), Nan Fung Trinity HK Ltd. ($463.65K), Allostery Investments LP ($244.99K), Goldman Sachs Group Inc. ($241.48K), and Persistent Asset Partners Ltd ($145.76K). How much institutional buying is happening at Climb Bio? Institutional investors have bought a total of 35,282,035 shares in the last 24 months. This purchase volume represents approximately $43.06M in transactions. Which of Climb Bio's major shareholders have been selling company stock? The following institutional investors have sold Climb Bio stock in the last 24 months: Geode Capital Management LLC ($362.09K), and JPMorgan Chase & Co. ($96.30K). How much institutional selling is happening at Climb Bio? Institutional investors have sold a total of 458,392 shares in the last 24 months. This volume of shares sold represents approximately $568.41K in transactions. Related Companies Arvinas Institutional Ownership Cullinan Therapeutics Institutional Ownership Gossamer Bio Institutional Ownership SNDL Institutional Ownership CryoPort Institutional Ownership PureTech Health Institutional Ownership Kodiak Sciences Institutional Ownership Tectonic Therapeutic Institutional Ownership Palvella Therapeutics Institutional Ownership Replimune Group Institutional Ownership This page (NASDAQ:CLYM) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGet This Stock NowThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredD.C.’s secret plan to crush the debt.At a recent gathering with some of the most powerful people in America, Jeff discovered the Trump administrati...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Climb Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Climb Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access